A61K 38/23
Calcitonins
A61K38/23 (Calcitonins) appears on 301 US grants and 354 published applications in this corpus.
Search patents in A61K- Granted patents
- 301
- Published applications
- 354
- Assignees
- 190
- Inventors
- 638
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 8 | 0 |
| 1997 | 16 | 0 |
| 1998 | 18 | 0 |
| 1999 | 17 | 0 |
| 2000 | 14 | 0 |
| 2001 | 5 | 5 |
| 2002 | 11 | 11 |
| 2003 | 12 | 21 |
| 2004 | 6 | 19 |
| 2005 | 11 | 25 |
| 2006 | 11 | 20 |
| 2007 | 4 | 22 |
| 2008 | 6 | 16 |
| 2009 | 8 | 23 |
| 2010 | 9 | 21 |
| 2011 | 10 | 12 |
| 2012 | 13 | 22 |
| 2013 | 11 | 18 |
| 2014 | 11 | 17 |
| 2015 | 10 | 17 |
| 2016 | 5 | 14 |
| 2017 | 8 | 8 |
| 2018 | 7 | 6 |
| 2019 | 9 | 9 |
| 2020 | 5 | 9 |
| 2021 | 3 | 5 |
| 2022 | 7 | 7 |
| 2023 | 1 | 11 |
| 2024 | 3 | 3 |
| 2025 | 6 | 8 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Stabilisation and controlled-release systems for medicaments unstable on sterilisation11 Nov 2025US 12,465,596 B2Fidia Farmaceutici S. P. A.
- Dosing of incretin pathway drugs23 Sep 2025US 12,420,014 B2Closed Loop Medicine Ltd.
- Branched degradable polyethylene glycol binder19 Aug 2025US 12,390,534 B2Nof Corporation
- Markers useful in enrichment strategies for the treatment of osteoarthritis12 Aug 2025US 12,383,603 B2Merck Patent GmbH
- Degradable polyethylene glycol conjugate4 Mar 2025US 12,239,713 B2Nof Corporation
- A method for preparing microparticles for drug delivery27 Aug 2026US 2026/0248735 A1Danmarks Tekniske Universitet
- Formulation of therapeutic agents for improved permeation9 Jul 2026US 2026/0191927 A1Vivtex Corporation
- Orally bioavailable lipid-based constructs21 May 2026US 2026/0137621 A1Diasome Pharmaceuticals, Inc.
- Compositions for enhanced mucosal penetration30 Apr 2026US 2026/0115140 A1Shin Nippon Biomedical Laboratories, Ltd.
- Markers useful in enrichment strategies for the treatment of osteoarthritis16 Apr 2026US 2026/0102469 A1Merck Patent GmbH
Most cited
By later US patents
- Oral compositions of proteinaceous medicaments303US 5,206,219 AApplied Analytical Industries, Inc. · 1993
- Diketopiperazine-based delivery systems228US 5,976,569 AEmisphere Technologies, Inc. · 1999
- Spray drying of macromolecules to produce inhaleable dry powders220US 6,582,728 B1Inhale Therapeutic Systems · 2003
- Bone growth factors and inhibitors of bone resorption for promoting bone formation219US 5,118,667 ACeltrix Pharmaceuticals, Inc. · 1992
- Oral drug delivery compositions and methods186US 5,792,451 AEmisphere Technologies, Inc. · 1998